Estradiol/progesterone - Innotesto
Alternative Names: GynadiolLatest Information Update: 28 Feb 2019
At a glance
- Originator INNOTESTO bvba
- Class Estradiol congeners; Estrenes; Hormonal replacements; Pregnenediones
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Menopausal syndrome
Most Recent Events
- 28 Feb 2019 No recent reports of development identified for phase-I development in Menopausal-syndrome in Belgium
- 12 Jan 2016 Phase-I clinical trials in Menopausal syndrome in Belgium (unspecified route)